About Lonza
Lonza is a company based in Houston (United States) founded in 2009 was acquired by Lonza in August 2010. It operates as a Managed Services and Professional Services. Lonza offers products and services including Viral Vectors Manufacturing, Process Development, and cGMP Manufacturing.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lonza
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lonza
Lonza offers a comprehensive portfolio of products and services, including Viral Vectors Manufacturing, Process Development, and cGMP Manufacturing.
Viral vectors are manufactured for gene therapy applications.
Processes are developed for scalable viral vector production.
cGMP manufacturing is provided for clinical and commercial needs.
Funding Insights of Lonza
Detailed funding history for Lonza
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Lonza
Lonza has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lonza.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
Locked | Locked | Locked |
Investor details for Lonza
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lonza
Investment portfolio details for Lonza
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lonza
Detailed financials for Lonza
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lonza Comparisons
Peer comparison for Lonza
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lonza
Detailed competitors of Lonza
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lonza
Complete news archive for Lonza
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lonza
Lonza was founded in 2009.
Lonza is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Lonza is involved in the development, clinical, and commercial manufacturing of viral vectors, including AAV, lentivirus, adenoviral, and oncolytic viruses. Services are provided across the biopharmaceutical sector, focusing on gene therapy applications. Solutions are offered for process development, scalability, and cGMP manufacturing, ensuring purity, potency, and regulatory compliance. Expertise is applied in analytical testing and process optimization to meet industry standards. Operations are conducted in specialized facilities designed to address key challenges in therapy manufacturing.
Lonza offers Viral Vectors Manufacturing, Process Development, and cGMP Manufacturing.
Lonza has 1 investor. Key investors include Lonza.